StockData
Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc. (PLRX) stock

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$0.66−0.03 (-4.76%)

Close on Nov 17, 2026Market cap $40.88MP/E –Yield 0.00%

Pliant Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Pliant Therapeutics's price to book ratio was 0.3× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.3× to 6.1×, with a median of 1.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.0
2025Dec 31, 20250.4×−1.9
2024Dec 31, 20242.3×+0.2
2023Dec 29, 20232.2×−0.6
2022Dec 30, 20222.8×+0.6
2021Dec 31, 20212.2×−0.5
2020Dec 31, 20202.7×–

More Pliant Therapeutics figures

See a number that looks wrong?